GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BPH Global Ltd (ASX:BP8) » Definitions » EV-to-FCF

BPH Global (ASX:BP8) EV-to-FCF : -2.92 (As of Apr. 14, 2025)


View and export this data going back to 2000. Start your Free Trial

What is BPH Global EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, BPH Global's Enterprise Value is A$2.47 Mil. BPH Global's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.84 Mil. Therefore, BPH Global's EV-to-FCF for today is -2.92.

The historical rank and industry rank for BPH Global's EV-to-FCF or its related term are showing as below:

ASX:BP8' s EV-to-FCF Range Over the Past 10 Years
Min: -62.57   Med: -4.75   Max: -0.55
Current: -2.92

During the past 13 years, the highest EV-to-FCF of BPH Global was -0.55. The lowest was -62.57. And the median was -4.75.

ASX:BP8's EV-to-FCF is ranked worse than
100% of 545 companies
in the Drug Manufacturers industry
Industry Median: 23.13 vs ASX:BP8: -2.92

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-14), BPH Global's stock price is A$0.003. BPH Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.003. Therefore, BPH Global's PE Ratio (TTM) for today is At Loss.


BPH Global EV-to-FCF Historical Data

The historical data trend for BPH Global's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BPH Global EV-to-FCF Chart

BPH Global Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.06 -7.96 -3.44 -1.94 -1.24

BPH Global Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.94 - -1.24 -

Competitive Comparison of BPH Global's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, BPH Global's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BPH Global's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BPH Global's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where BPH Global's EV-to-FCF falls into.


;
;

BPH Global EV-to-FCF Calculation

BPH Global's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2.468/-0.844
=-2.92

BPH Global's current Enterprise Value is A$2.47 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BPH Global's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BPH Global  (ASX:BP8) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

BPH Global's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.003/-0.003
=At Loss

BPH Global's share price for today is A$0.003.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BPH Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.003.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


BPH Global EV-to-FCF Related Terms

Thank you for viewing the detailed overview of BPH Global's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


BPH Global Business Description

Traded in Other Exchanges
N/A
Address
96 Elizabeth Street, Block Arcade, Office 324, Level 3, Melbourne, VIC, AUS, 3000
BPH Global Ltd is a marine and agricultural biotechnology industry. Its only operating segment is sourcing, producing, marketing, and selling traditional medicines. The company's geographical segment includes Australia; Singapore; Malaysia and China. The company's product comprises Cannabis sativa; Dendrobium Officinale and Daemonorops Draco Blume.

BPH Global Headlines

No Headlines